Show simple item record

dc.contributor.authorMayito, Jonathan
dc.contributor.authorKibombo, Daniel
dc.contributor.authorOlaro, Charles
dc.contributor.authorNabadda, Susan
dc.contributor.authorGuma, Consolata
dc.contributor.authorNabukenya, Immaculate
dc.contributor.authorBusuge, Andrew
dc.contributor.authorDhikusooka, Flavia
dc.contributor.authorAndema, Alex
dc.contributor.authorMukobi, Peter
dc.contributor.authorOnyachi, Nathan
dc.contributor.authorWatmon, Ben
dc.contributor.authorObbo, Stephen
dc.contributor.authorYayi, Alfred
dc.contributor.authorElima, James
dc.contributor.authorBarigye, Celestine
dc.contributor.authorNyeko, Filbert J.
dc.contributor.authorMugerwa, Ibrahim
dc.contributor.authorSekamatte, Musa
dc.contributor.authorBazira, Joel
dc.contributor.authorWalwema, Richard
dc.contributor.authorLamorde, Mohammed
dc.contributor.authorKakooza, Francis
dc.contributor.authorKajumbula, Henry
dc.date.accessioned2024-04-09T09:25:39Z
dc.date.available2024-04-09T09:25:39Z
dc.date.issued2024
dc.identifier.citationMayito, J., Kibombo, D., Olaro, C., Nabadda, S., Guma, C., Nabukenya, I., ... & Kajumbula, H. (2024). Characterization of Antibiotic Resistance in Select Tertiary Hospitals in Uganda: An Evaluation of 2020 to 2023 Routine Surveillance Data. Tropical Medicine and Infectious Disease, 9(4), 77.en_US
dc.identifier.urihttp://ir.must.ac.ug/xmlui/handle/123456789/3551
dc.description.abstractAntimicrobial resistance (AMR) is a public health concern in Uganda. We sought to conduct an extended profiling of AMR burden at selected Ugandan tertiary hospitals. We analyzed routine surveillance data collected between October 2020 and March 2023 from 10 tertiary hospitals. The analysis was stratified according to the hospital unit, age, gender, specimen type, and time. Up to 2754 isolates were recovered, primarily from pus: 1443 (52.4%); urine: 1035 (37.6%); and blood: 245 (8.9%). Most pathogens were Staphylococcus aureus, 1020 (37%), Escherichia coli, 808 (29.3%), and Klebsiella spp., 200 (7.3%). Only 28% of Escherichia coli and 42% of the other Enterobacterales were susceptible to ceftriaxone, while only 44% of Staphylococcus aureus were susceptible to methicillin (56% were MRSA). Enterococcus spp. susceptibility to vancomycin was 72%. The 5–24-year-old had 8% lower ampicillin susceptibility than the >65-year-old, while the 25–44-year-old had 8% lower ciprofloxacin susceptibility than the >65-year-old. The 0–4-year-old had 8% higher ciprofloxacin susceptibility. Only erythromycin susceptibility varied by sex, being higher in males. Escherichia coli ciprofloxacin susceptibility in blood (57%) was higher than in urine (39%) or pus (28%), as was ceftriaxone susceptibility in blood (44%) versusurine (34%)orpus(14%). Klebsiellaspp. susceptibility to ciprofloxacin and meropenem decreased by 55% and 47%, respectively, during the evaluation period. During the same period, Escherichia coli ciprofloxacin susceptibility decreased by 40%, while Staphylococcus aureus gentamicin susceptibility decreased by 37%. Resistance was high across the Access and Watch antibiotic categories, varying with time, age, sex, specimen type, and hospital unit. Effective antimicrobial stewardship targeted at the critical AMR drivers is urgently needed.en_US
dc.language.isoen_USen_US
dc.publisherTropical Medicine and Infectious Diseaseen_US
dc.subjectAntimicrobial resistanceen_US
dc.subjectAMRen_US
dc.subjectAntibiotic resistanceen_US
dc.subjectBacterial antimicrobial resistanceen_US
dc.subjectAMR surveillanceen_US
dc.titleCharacterization of Antibiotic Resistance in Select Tertiary Hospitals in Uganda: An Evaluation of 2020 to 2023 Routine Surveillance Dataen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record